Overview:
Despite being a preventable and treatable condition, postpartum hemorrhage (PPH) the leading direct cause of maternal deaths worldwide. However, women in low respurce stings may not have desired access to appropriate care. This condition causes approximately 25% of the total maternal deaths. PPH is defined as excessive vaginal bleeding and occurs in over 10% of the total births and is linked with 1% case fatality rate. Active management of third stage labor can prevent up to 60% PPH cases, it still has devastating effect in low-income countries. Currently PPH causes approximately 34% and 31% of maternal deaths in Africa and Asia, whereas 31% in Caribbean and Latin America. A majority of primary PPH cases are caused byb uterine atony and result in prolonged labor, and preclampsia.
Among the available products for treating PPH, uterine balloon tamponades segment currently experiences the highest demand. Better effectiveness, ease of use and wide availability are the key factors contributing to the dominance of this segment. Additionally, the demand for uniject prefilled injection systems is expected to be the highest during the forecast period. Ease of application, greater support from governments and convenient pricing mainly support the rapid growth of this segment. On the other hand, non-pneumatic anti-shock garment (NASG) segment will undergo satisfactorily fast market growth during the forecast period.
North America currently holds over 30% of the global share thereby dominating the market. Higher hospital birth rates, greater awareness among patients and healthcare providers and favorable government policies fuel the lead of North America market. The demand for PPH treatment devices will be the highest in Asia Pacific due to greater population pool and and swift evolution of healthare infrastructure. Additionally, increase in the number of welfare initiatives undertaken by governments for augmenting hospital births and preventing maternal deaths will also assist in boosting the demand for novel PPH treatment devices during the forecast period.
The global Postpartum Hemorrhage Treatment Devices market is segmented on the following bases:
- Product Type
- Uterine balloon tamponade
- Bakri balloon tamponade
- Condom catheter
- Foley catheter
- BT-Cath balloon
- Uniject prefilled injection system
- Non-pneumatic anti-shock garment (NASG)
Geography
-
- North America
- Europe
- UK
- Germany
- Rest of Europe
- Asia Pacific
- Latin America
- The Middle East and Africa
- GCC
- Rest of the Middle East and Africa
Some key players identified for Postpartum Hemorrhage Treatment Devices market include:
C. R. Bard, Inc., Cook Medical, Inc., Becton Dickinson and Company, Teleflex Incorporated, Bactiguard AB, Utah Medical Products Inc., and others
This report offers:
- Analysis of several products, and regions that would provide clear understanding of the ongoing and future trends in the global postpartum hemorrhage treatment market
- Assessment of market dynamics such as drivers, restraints, and opportunities prevalent in the market
- Quantitative assessment of the current market size and future estimations for the period from 2016 to 2026, along with CAGRs for the period from 2018 to 2026
- Company profiles that will highlight key information about the imperative players operating in the global postpartum hemorrhage treatment devices market
